Importantly, the absolute number and fraction of tumor antigen–specific CD8+ T cells were significantly increased in tumors from mice treated with YJ1206 alone or in combination with anti–PD-1 (Figure 6D and Supplemental Figure 9F). The gene discussed is CD8A; the disease is neoplasm.